Jennifer Lachey

2020

In 2020, Jennifer Lachey earned a total compensation of $3.5M as Chief Scientific Officer at Keros Therapeutics, a 755% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$154,200
Option Awards$3,017,362
Salary$370,196
Other$521
Total$3,542,278

Lachey received $3M in option awards, accounting for 85% of the total pay in 2020.

Lachey also received $154.2K in non-equity incentive plan, $370.2K in salary and $521 in other compensation.

Rankings

In 2020, Jennifer Lachey's compensation ranked 3,269th out of 13,090 executives tracked by ExecPay. In other words, Lachey earned more than 75.0% of executives.

ClassificationRankingPercentile
All
3,269
out of 13,090
75th
Division
Manufacturing
1,267
out of 5,618
77th
Major group
Chemicals And Allied Products
477
out of 2,251
79th
Industry group
Drugs
413
out of 1,951
79th
Industry
Pharmaceutical Preparations
307
out of 1,456
79th
Source: SEC filing on April 19, 2021.

Lachey's colleagues

We found two more compensation records of executives who worked with Jennifer Lachey at Keros Therapeutics in 2020.

2020

Jasbir Seehra

Keros Therapeutics

Chief Executive Officer

2020

Keith Regnante

Keros Therapeutics

Chief Financial Officer

News

In-depth

You may also like